One notable technique is the utility of liquid biopsies to provide real-time insights into tumor evolution and treatment response. Liquid biopsies are part...
Using radioactive ligand binding methods, Dr. Snyder’s team found that the receptors were highly concentrated in areas of the brain involved in the s...
With an effective process validation regimen – with proper documentation and protocol testing to address product identity, strength, quality, purity,...
LC/MS/MS instruments use two quadrupole mass analyzers in series, with a collision cell in between, to provide higher sensitivity and selectivity for targe...
But developing a bispecific antibody presents several challenges, including those related to dual binding, screening, pharmacodynamics, tissue tropism, and...
Unlocking early biological changes Fluorescence imaging offers researchers a unique opportunity to understand the early biological changes associated with...
These figures were disappointing for many, especially since TB is a treatable disease. The standard treatment typically requires six months of antibiotics...
“Every tumor is different, and the one-size-fits-all approach doesn’t work for patients,” said Dr. Nikolaus Krall, Vice President Preci...
In contrast to the success of CAR T-cell therapies in liquid cancers, development for the treatment of solid tumors, including glioblastoma, has progressed...
Key Advantages of Using In Vivo Fluorescence Imaging Non-invasive approach In vivo fluorescence imaging is a non-invasive technique that uses light to vi...
To help address these challenges, the cell counting experts at Nexcelom, now part of PerkinElmer, have identified six key points to increase the confidence...
Largely driven by increasing incidence of chronic and infectious diseases and growth in biotechnology and pharma industries, the global immunoassay market ...
There is growing recognition that the experimental model systems used in many cancer research projects, which include 2D cell cultures, patient-derived xen...
But a game-changer occurred in 2013, when several researchers showed that a gene-editing tool called CRISPR could alter the DNA of human cells like a v...
© 2024 Biopharma Boardroom. All Rights Reserved.
